R A Stockley

3.7k total citations
61 papers, 2.8k citations indexed

About

R A Stockley is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cancer Research. According to data from OpenAlex, R A Stockley has authored 61 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 13 papers in Physiology and 10 papers in Cancer Research. Recurrent topics in R A Stockley's work include Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Cystic Fibrosis Research Advances (13 papers) and Asthma and respiratory diseases (12 papers). R A Stockley is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Cystic Fibrosis Research Advances (13 papers) and Asthma and respiratory diseases (12 papers). R A Stockley collaborates with scholars based in United Kingdom, United States and Japan. R A Stockley's co-authors include Susan L. Hill, David Burnett, Anita Pye, D Bayley, Christine O’Brien, A. T. Hill, Lee Dowson, Peter Guest, David Thickett and S. L. Hill and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

R A Stockley

59 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R A Stockley United Kingdom 28 1.9k 863 350 343 312 61 2.8k
C. M. O’Connor Ireland 30 1.6k 0.9× 588 0.7× 356 1.0× 453 1.3× 184 0.6× 66 2.7k
Tomoko Suzuki Japan 27 1.1k 0.6× 606 0.7× 484 1.4× 635 1.9× 494 1.6× 80 2.7k
André Bernard Tonnel France 28 1.2k 0.7× 1.3k 1.5× 582 1.7× 280 0.8× 390 1.3× 59 2.9k
Katsutoshi Nakayama Japan 26 1.3k 0.7× 698 0.8× 354 1.0× 660 1.9× 752 2.4× 74 2.6k
Esmaeil Mortaz Iran 30 862 0.5× 710 0.8× 777 2.2× 713 2.1× 373 1.2× 154 2.8k
Roger S. Thrall United States 33 1.2k 0.6× 693 0.8× 718 2.1× 599 1.7× 250 0.8× 96 3.1k
Annemarie van Schadewijk Netherlands 28 1.1k 0.6× 790 0.9× 717 2.0× 552 1.6× 251 0.8× 52 2.6k
A P Greening United Kingdom 33 2.5k 1.3× 1.9k 2.2× 520 1.5× 462 1.3× 247 0.8× 60 3.8k
Raimundas Sakalauskas Lithuania 22 1.1k 0.6× 893 1.0× 433 1.2× 325 0.9× 133 0.4× 110 2.0k
Christian Herr Germany 29 645 0.3× 491 0.6× 487 1.4× 583 1.7× 195 0.6× 94 2.2k

Countries citing papers authored by R A Stockley

Since Specialization
Citations

This map shows the geographic impact of R A Stockley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R A Stockley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R A Stockley more than expected).

Fields of papers citing papers by R A Stockley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R A Stockley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R A Stockley. The network helps show where R A Stockley may publish in the future.

Co-authorship network of co-authors of R A Stockley

This figure shows the co-authorship network connecting the top 25 collaborators of R A Stockley. A scholar is included among the top collaborators of R A Stockley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R A Stockley. R A Stockley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stockley, R A, Ingrid Louise Titlestad, Hanan Tanash, et al.. (2023). Alvelestat, an Oral Neutrophil Elastase Inhibitor in Alpha-1 Antitrypsin Deficiency (AATD): Results of a Phase II Trial. A4493–A4493.
2.
Edgar, Ross, et al.. (2014). P58 A Comparison Between The Clinical Features Of Pisz And Pizz Patients With Alpha-1 Antitrypsin Deficiency. Thorax. 69(Suppl 2). A100–A100. 3 indexed citations
3.
Bayley, D, et al.. (2008). Validation of assays for inflammatory mediators in exhaled breath condensate. European Respiratory Journal. 31(5). 943–948. 35 indexed citations
4.
Stockley, R A, et al.. (2007). The Interaction of Host and Pathogen Factors in Chronic Obstructive Pulmonary Disease Exacerbations and Their Role in Tissue Damage. Proceedings of the American Thoracic Society. 4(8). 611–617. 4 indexed citations
5.
Dowson, Lee, et al.. (2001). Exercise Capacity Predicts Health Status in α1-Antitrypsin Deficiency. American Journal of Respiratory and Critical Care Medicine. 163(4). 936–941. 54 indexed citations
6.
Dowson, Lee, Peter Guest, & R A Stockley. (2001). Longitudinal Changes in Physiological, Radiological, and Health Status Measurements in α1-Antitrypsin Deficiency and Factors Associated with Decline. American Journal of Respiratory and Critical Care Medicine. 164(10). 1805–1809. 134 indexed citations
7.
Stockley, R A, Christine O’Brien, Anita Pye, & Susan L. Hill. (2000). Relationship of Sputum Color to Nature and Outpatient Management of Acute Exacerbations of COPD. CHEST Journal. 117(6). 1638–1645. 360 indexed citations
8.
Viglio, Simona, Paolo Iadarola, Alessandro Lupi, et al.. (2000). MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. European Respiratory Journal. 15(6). 1039–1039. 87 indexed citations
9.
Hill, A. T., D Bayley, & R A Stockley. (1999). The Interrelationship of Sputum Inflammatory Markers in Patients with Chronic Bronchitis. American Journal of Respiratory and Critical Care Medicine. 160(3). 893–898. 173 indexed citations
10.
Hill, A. T., Edward J. Campbell, D Bayley, Susan L. Hill, & R A Stockley. (1999). Evidence for Excessive Bronchial Inflammation during an Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Patients with α1-Antitrypsin Deficiency (PiZ). American Journal of Respiratory and Critical Care Medicine. 160(6). 1968–1975. 134 indexed citations
11.
Stockley, R A. (1999). Neutrophils and Protease/Antiprotease Imbalance. American Journal of Respiratory and Critical Care Medicine. 160(Supplement_1). S49–S52. 209 indexed citations
12.
Dyer, Christopher, et al.. (1999). Quality of life in elderly subjects with a diagnostic label of asthma from general practice registers. European Respiratory Journal. 14(1). 39–39. 53 indexed citations
13.
Bayley, D, et al.. (1998). The Chemotactic Activity of Sputum from Patients with Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 157(3). 723–728. 77 indexed citations
14.
Stockley, R A, et al.. (1996). Effect of Fluticasone Propionate on Sputum of Patients With Chronic Bronchitis and Emphysema. American Journal of Respiratory and Critical Care Medicine. 153(2). 616–621. 106 indexed citations
15.
Pye, Anita, R A Stockley, & S. L. Hill. (1995). Simple method for quantifying viable bacterial numbers in sputum.. Journal of Clinical Pathology. 48(8). 719–724. 54 indexed citations
16.
Stockley, R A, et al.. (1994). Neutrophil Formyl-Peptide Receptors. Relationship to Peptide-Induced Responses and Emphysema. American Journal of Respiratory and Critical Care Medicine. 149(2). 464–468. 34 indexed citations
17.
Burnett, David, David Adams, T. John Martin, et al.. (1994). Inhibition by FK506 of formyl peptide-induced neutrophil activation and associated protein synthesis. Biochemical Pharmacology. 48(6). 1081–1088. 12 indexed citations
18.
Hill, S. L., et al.. (1989). Activities and sources of beta-lactamase in sputum from patients with bronchiectasis. Journal of Clinical Microbiology. 27(5). 1055–1061. 13 indexed citations
19.
Lacey, R. W., D S Tompkins, M. Millar, et al.. (1983). HIGH-DOSE AMOXYCILLIN. The Lancet. 322(8361). 1258–1259. 1 indexed citations
20.
Hill, S L, et al.. (1981). Elastolytic Activity and Protein Studies of Sol-Phase Sputum from Patients with Cystic Fibrosis. Clinical Science. 61(3). 32P–32P. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. M. O’Connor Breakdown of academic impact, for papers by Tomoko Suzuki Breakdown of academic impact, for papers by André Bernard Tonnel Breakdown of academic impact, for papers by Katsutoshi Nakayama Breakdown of academic impact, for papers by Esmaeil Mortaz Breakdown of academic impact, for papers by Roger S. Thrall Breakdown of academic impact, for papers by Annemarie van Schadewijk Breakdown of academic impact, for papers by A P Greening Breakdown of academic impact, for papers by Raimundas Sakalauskas Breakdown of academic impact, for papers by Christian Herr
Rankless by CCL
2026